Hae Mi Choe, PharmD

Articles

5-ASA to Sulfasalazine Drug Switch Program in Patients With Ulcerative Colitis

July 11, 2018

A 5-aminosalicylic acid (5-ASA) drug switch program switching from 5-ASA to sulfasalazine was instituted for insured patients with ulcerative colitis. Unanticipated barriers limited the number of patients who switched, but significant cost savings were still obtained.